Was that doctor truly unaware of the muscle loss concerns prior to January of 2025 (date of the article)? And he also failed to understand that pharma viewed these drugs as a subscription plan rather than a cure? I'm not big on hurling insults around, but perhaps if he's been this hopelessly naive in the past, he should recognize his shortcomings and let others with better critical thinking skills author the contrarian articles of this sort. LOL
The article raises valid concerns. If one were paying full retail price ($1000+ per month in prior years), I can see where it might feel like extortion to have to keep paying that to maintain a stalled out weight loss and avoid regain, but I suspect many here aren't too worried about the financial aspect. The muscle-loss concerns are rather controversial as well with different studies showing different results in regards to body composition results and that likely varying across different formulations.
I think those who view GLP1's as first-line weight loss methods (while failing to address underlying food addiction issues or investigate their own relationship with food) may be disappointed, but like any other tool, these drugs have strong use cases for many people.